Patent classifications
A61N1/37516
CONNECTION METHOD FOR CONNECTING AN ISOLATED MICRO-CONDUCTOR
The present invention relates to a method for connecting a strand of a multi-strand cable to an electrode of an implantable medical device. The method includes cutting a strand of the multi-strand cable lifting at least one of the free ends, stripping the end of the lifted strand, placing an electrode around the multi-strand cable to partially cover the end of the lifted and stripped stand, and connecting at least one portion of the stripped end of the strand to the electrode.
Methods, systems, and apparatus for closed-loop neuromodulation
Systems, apparatus, and methods for treating medication refractory epilepsy are disclosed. In one embodiment, a method of treating epilepsy is disclosed comprising detecting, using a first electrode array coupled to a first endovascular carrier, an electrophysiological signal of a subject. The method further comprises analyzing the electrophysiological signal using a neuromodulation unit electrically coupled to the first electrode array and stimulating an intracorporeal target of the subject using a second electrode array coupled to a second endovascular carrier implanted within a part of a bodily vessel superior to a base of the skull of the subject.
SYSTEM AND METHOD FOR UNIPHASIC AND BIPHASIC SHOCK INVERSION TIME DOMAIN SHIFTING FOR SHOCK ENERGY VECTORING IN TRANSVENOUS AND SUBCUTANEOUS DEFIBRILLATORS WITH TWO OR MORE SHOCK VECTORS
Method for truncating and summating shock vector energy between at least two shock vectors in a defibrillator, including the procedures of applying at least two biphasic defibrillating shock vectors simultaneously via at least two electrode sets until a voltage inversion point, terminating at least a first one of the biphasic defibrillating shock vectors at the voltage inversion point, and directing a remaining energy of the first one of the biphasic defibrillating shock vectors to a second phase of at least a second one of the biphasic defibrillating shock vectors.
Implantable medical device with proximal capture feature
The present subject matter includes an implantable medical device with a capture feature at or near the proximal end. In some cases, the capture feature includes a hold that is configured to facilitate a releasable connection with a delivery device that is used to deliver the implantable medical device to a target implant site.
APPARATUS USED TO DETECT OR STIMULATE ACTIVITY OF NERVE TISSUE
This apparatus (1) comprises at least one intravascular device (10), (20) that is disposed in a blood vessel of an organism and that is equipped with at least one electrode (11), (12), (21), (22) for detecting or stimulating the activity of nerve tissue positioned outside the blood vessel nearby, the electrodes (11), (12), (21), (22) being provided on a wire member.
Intravenous / Intra-Spinal / Intra-Cavity / Intraventricular Delivery of TTFields (Tumor Treating Fields) for Treating Cancer and Metastases
Tumor treating fields (TTFields) may be applied to a person's body using six different types of electrodes. More specifically, the electrodes may be shaped and dimensioned (a) for insertion into blood vessels so that they make contact with the person's blood; (b) for insertion into a central canal of a spinal cord, so that they make contact with the CSF; (c) for insertion into a body orifice at a position that contacts an interior surface of the person's body; (d) for affixation to skin of the person's body (e.g., on the person's head, torso, back, abdomen, etc.); (e) for insertion into a brain ventricle so that they make contact with the person's CSF; or (f) for insertion into lymph vessels so that they make contact with the person's lymph. Applying an AC voltage between any two of these electrodes will create TTFields in respective parts of the person's body.
Electrode Lead with Continuously Variable Fixation Length
An electrode lead for the coronary sinus, with a lead body that has a distal section for insertion into the coronary sinus, and at least one electrode to make contact with body tissue, the at least one electrode being arranged on the distal section of the lead body. The electrode lead has a fixation device that can be extended out of the lead body to fix the electrode lead in a blood vessel.
Electrode Lead with Fixing Device
A fixing device for fixing an implantable electrode lead in a blood vessel, which fixing device has a main body with a substantially circular cross-section, and at least one resilient fixing element arranged on the main body in a contact region, wherein the fixing element extends in a first direction of extent in an axial direction in respect of the main body, extends away from the main body starting from the contact region, and wherein the fixing element encloses an angle of less than 45-degrees with a tangent running through the contact region. Also provided is an implantable electrode lead comprising this fixing device.
IMPLANT IN MIDDLE MENINGIAL-ARTERY
An implant sized and shaped to be endovascularly delivered to the middle meningeal artery includes a carrier that carries a payload between first and second ends thereof. An anchor mechanism associated with the implant transitions into a swollen state in response to exposure to bodily fluids. In the swollen state, said anchor mechanism anchors the implant to the middle meningeal artery. Before or during the transition, the anchor mechanism permits endovascular delivery of the implant to the middle meningeal artery.
SEPARATE POSITIONABLE HEMOSTASIS VALVE FOR IMPLANTABLE MEDICAL LEAD INTRODUCER HUB
A medical system including an implantable medical, the lead comprising a lead body and a helical electrode at least one of extending or extendable from a distal end of the lead body. The medical system including a hemostasis valve coupled to the lead body proximal the distal end of the lead body, the hemostasis valve configured to slide along the lead body. The distal end of the lead body is configured for insertion into an introducer hub positioned in an opening into a vasculature of a patient and the lead body configured for subsequent advancement through the introducer hub to facilitate securing the hemostasis value to the introducer hub. The hemostasis valve is configured for slidable advancement of the lead body therethrough for continued advancement of the lead body through the introducer hub.